Uncategorized
Kala Pharmaceuticals to Present Update on Phase 3 Programs at the 35th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc announced today that Mark Iwicki, Chairman and Chief Executive Officer of Kala, is scheduled to present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco.